A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity - Eli Lilly and CompanySee more
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor - Novo Nordisk A/SSee more
Obesity
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease - TRIUMPH-3 - Eli Lilly and CompanySee more
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity - Eli Lilly and CompanySee more
Cardiovascular disease
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease - TRIUMPH-3 - Eli Lilly and CompanySee more
